way 100135 has been researched along with morphine in 3 studies
| Studies (way 100135) | Trials (way 100135) | Recent Studies (post-2010) (way 100135) | Studies (morphine) | Trials (morphine) | Recent Studies (post-2010) (morphine) |
|---|---|---|---|---|---|
| 143 | 0 | 34 | 44,270 | 5,200 | 8,695 |
| Protein | Taxonomy | way 100135 (IC50) | morphine (IC50) |
|---|---|---|---|
| Delta-type opioid receptor | Mus musculus (house mouse) | 0.2939 | |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.2278 | |
| Kappa-type opioid receptor | Mus musculus (house mouse) | 0.0828 | |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0385 | |
| Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0545 | |
| Mu-type opioid receptor | Homo sapiens (human) | 0.122 | |
| Delta-type opioid receptor | Homo sapiens (human) | 0.1199 | |
| Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.9308 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 0.655 | |
| Mu-type opioid receptor | Mus musculus (house mouse) | 0.3305 | |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.202 | |
| Beta-2 adrenergic receptor | Cavia porcellus (domestic guinea pig) | 0.25 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Esteban, S; García-Sevilla, JA; Sastre-Coll, A | 1 |
| Rezayof, A; Tirgar, F; Zarrindast, MR | 1 |
| Abbasi-Maleki, S; Mesbahzadeh, B; Moradi-Kor, N | 1 |
3 other study(ies) available for way 100135 and morphine
| Article | Year |
|---|---|
Supersensitivity of 5-HT1A autoreceptors and alpha2-adrenoceptors regulating monoamine synthesis in the brain of morphine-dependent rats.
Topics: 5-Hydroxytryptophan; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Autoreceptors; Biogenic Monoamines; Brain; Dihydroxyphenylalanine; Male; Morphine; Morphine Dependence; Naloxone; Narcotics; Norepinephrine; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Receptor Agonists; Substance Withdrawal Syndrome | 2002 |
Central amygdala nicotinic and 5-HT1A receptors mediate the reversal effect of nicotine and MDMA on morphine-induced amnesia.
Topics: Amnesia; Animals; Central Amygdaloid Nucleus; Dose-Response Relationship, Drug; Male; Mecamylamine; Morphine; N-Methyl-3,4-methylenedioxyamphetamine; Narcotics; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Piperazines; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Receptors, Nicotinic; Serotonin 5-HT1 Receptor Antagonists; Serotonin Agents | 2014 |
Zinc enhances the expression of morphine-induced conditioned place preference through dopaminergic and serotonergic systems.
Topics: Animals; Benzazepines; Conditioning, Psychological; Dopamine Antagonists; Haloperidol; Ketanserin; Male; Morphine; Ondansetron; Piperazines; Rats; Rats, Wistar; Reward; Serotonin Antagonists; Sulpiride; Zinc | 2019 |